Calculate your risk assessment for chromosomal abnormalities based on NT measurement, maternal age, and blood markers.
This is considered a low-risk result. Your chance is similar to the general population risk for your age.
1 in 850
Population risk: 1 in 1,0001 in 5,000
Trisomy 18 risk1 in 8,000
Trisomy 13 risk85-90%
With combined screeningBased on your low-risk result, no further invasive testing is typically recommended. Continue with routine prenatal care.
Next Steps: Routine anomaly scan at 18-20 weeks.
Nuchal translucency (NT) is a sonographic feature representing the normal subcutaneous fluid-filled space between the back of the fetal neck and the overlying skin.
The NT measurement, when combined with maternal age and blood markers, helps assess the risk of:
11 weeks: Normal range: 1.0-2.0 mm
12 weeks: Normal range: 1.0-2.5 mm
13 weeks: Normal range: 1.0-2.8 mm
14 weeks: Normal range: 1.0-3.0 mm
The NT scan is typically performed between 11 and 14 weeks of pregnancy.
Risk less than 1 in 250. No further testing typically recommended.
Risk between 1 in 250 and 1 in 1000. Consider non-invasive prenatal testing (NIPT).
Risk greater than 1 in 250. Discuss diagnostic testing options with your doctor.
This calculator provides an estimate based on statistical models. It is NOT a medical diagnosis. Always consult with your healthcare provider for professional medical advice and interpretation of your screening results.
The results should be discussed with a genetic counselor or obstetrician who can consider your complete medical history and provide personalized recommendations.